HNSCC
Clinical trials for HNSCC explained in plain language.
Never miss a new study
Get alerted when new HNSCC trials appear
Sign up with your email to follow new studies for HNSCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharged immune cells take on advanced cancers in new trial
Disease control OngoingThis early-stage trial tests a new treatment for people with advanced solid tumors (like head and neck, melanoma, or lung cancer) that haven't responded to standard therapies. Doctors take a patient's own immune cells from the tumor, pick out the ones best at fighting cancer, gro…
Matched conditions: HNSCC
Phase: PHASE1 • Sponsor: AgonOx, Inc. • Aim: Disease control
Last updated May 26, 2026 04:08 UTC
-
New drug combo shows promise in fighting tough head and neck cancers
Disease control OngoingThis study tests whether adding ramucirumab to the standard immunotherapy pembrolizumab works better than pembrolizumab alone for people with advanced head and neck cancer that has come back or spread. The trial includes 37 adults whose tumors have a specific marker (PD-L1 positi…
Matched conditions: HNSCC
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 04:04 UTC
-
New drug cocktail aims to boost survival in early oral cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug tirellizumab and chemotherapy before surgery can improve outcomes for people with early-stage oral cancer. About 60 participants will be randomly assigned to either the new drug combo plus surgery or standard surgery alone. T…
Matched conditions: HNSCC
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New program aims to slash cancer diagnosis delays in botswana
Knowledge-focused OngoingThis study tests a program called Potlako+ that combines community education, help for healthcare workers, and patient guides to speed up cancer detection and treatment. About 874 adults in Botswana with possible cancer symptoms will take part. Half of the communities get the pro…
Matched conditions: HNSCC
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:53 UTC